Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
14-patient study finds Ozempic combined with ReCET procedure may eliminate insulin need for type 2 diabetes patients after six months.
A small study suggests that the diabetes drug Ozempic, combined with a new intestinal procedure called ReCET, may eliminate the need for insulin in type 2 diabetes patients.
Involving 14 participants, the study found that 12 no longer required insulin after six months.
The ReCET procedure targets the duodenum to improve its function.
However, due to the small sample size, further research is necessary to confirm these initial results.
17 Articles
En un estudio con 14 pacientes, Ozempic combinado con el procedimiento ReCET puede eliminar la necesidad de insulina en pacientes con diabetes tipo 2 al cabo de seis meses.